3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.

      Rheumatology (Oxford, England)
      Animals, Arthritis, Rheumatoid, immunology, therapy, Dendrimers, Gene Silencing, drug effects, Group IV Phospholipases A2, genetics, Humans, Macrophages, enzymology, Molecular Targeted Therapy, methods, Monocytes, RNA, Small Interfering, therapeutic use, Tumor Necrosis Factor-alpha

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.

          Related collections

          Author and article information

          Comments

          Comment on this article